The spectrum of mycobacterial infection after lung transplantation

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 5 I, 1999, Pages 1611-1616

  Malouf, Monique A ^a   Glanville, Allan R ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOSPORIN; DNA; ETHAMBUTOL; LYMPHOCYTE ANTIBODY; PREDNISOLONE; RIFAMPICIN; TACROLIMUS;

ADULT; ARTICLE; BACTERIUM CULTURE; DNA PROBE; FEMALE; FOLLOW UP; GRAFT REJECTION; HUMAN; INCIDENCE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SURVIVAL;

EID: 0032747102     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.5.9808113     Document Type: Article

References (19)

1. Brooks, R. G., J. M. Hofflin, S. W. Jamieson, E. B. Stinson, and J. S. Remington. 1985. Infectious complications in heart-lung transplant recipients. Am. J. Med. 79:412-422.
2. Dummer, J. S., C. G. Montcro, B. P. Griffith, R. L. Hardesly, I. L. Paradis, and M. Ho. 1986. Infections in heart-lung transplant recipients. Transplantation 41:725-729.
3. Dromer, C., S. Nasef, J. F. Velly, C. Martigne, and L. Couraud. 1993. Tuberculosis in transplanted lungs. J. Heart Lung Transplant. 12(6):924-927.
4. Miller, R. A., L. A. Louis, J. N. Kline, and L. J. Geist. 1995. Mycobacterium tuberculosis in lung transplant recipients. Am. J. Respir. Crit. Care Med. 152:374-376.
5. American Thoracic Society. 1997. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am. J. Respir. Crit. Care Med. 156:S1-S25.
6. Ahn, C. H., J. W. McLarty, S. I. Ahn, and G. A. Hurst. 1982. Diagnostic criteria for pulmonary disease caused by Mycobacterium kansasii and Mycobacterium intracellulare. Am. Rev, Respir, Dis. 105:683-714.
7. Patel, R., G. D. Roberts, M. R. Keating, and C. V. Paya. 1994. Infections due to nontuberculous mycobacteria in kidney, heart and liver transplant recipients. Clin. Infect. Dis. 19:263-273.
8. Griffith, D. E., B. A. Brown, W. M. Girard, and R. J. Wallace, Jr. 1995. Adverse events associated with high dose rifahutin in macrolide containing regimens for the treatment of Mycobacterium avium complex lung disease. Clin. Infect. Dis. 21:594-598.
9. Narang, P. K., C. B. Trapnell, J. R. Schoenfelder, J. P. Lavelle, and J. R. Bianchine. 1994. Fluconazole and enhanced effect of rifabutin prophylaxis [Letter]. N. Engl. J. Med. 330(11):1316-1317.
10. Modry, D. L., E. B. Stinson, P. E. Oyer, S. W. Jamieson, J. C. Baldwin, and N. E. Shumway. 1993. Acute rejection and massive cyclosprine requirements in heart transplant recipients treated with rifampicin. Transplantation 39(3):313-314.
11. Offerman, G., F. Keller, and M. Molzahn. 1985. Low cyclosporine A blood levels and acute graft rejection in a renal transplant recipient during rifampin treatment. Am. J. Nephrol. 5:385-387.
12. Buffington, G. A., J. H. Dominguez, W. F. Piering, L. A. Herbert, M. Kauffman, Jr., and J. Lemann, Jr. 1958. Interaction of rifampicin and glucocorticoids. J.A.M.A. 236(17):1958-1960.
13. Kramer, M. R., G. Merin, E. Rudis, I. Bar, T. Nesher, M. Bublil, and E. Milgalter. 1997. Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and Tacrolimus (FK506). Transplant Proc. 29:2657-2659.
14. American Thoracic Society. 1994. Treatment of tuberculosis and tuberculosis infection in adults and children. Am. J. Respir. Crit. Care Med. 149:1359-1374.
15. Saubolle, M. A., T. E. Kichn, M. H. White, M. F. Rudinsky, and D. Armstrong. 1996. Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin. Microbiol. Rev. 9:435-447.
16. Gouby, A., B. Branger, R. Oules, and M. Ramuz. 1988. Two cases of Mycobacterium infection in a renal dialysis unit. J. Med. Microbiol. 25:46-49.
17. Perronne, C., A. Gikas, C. Truffot-Pernot, J. Grosset, J. L. Vilde, and J. J. Pocidalo. 1991. Activities of sparfloxacin, azithromycin, temafloxacin and rifabutin compared with that of clarithromycin against multiplication of Mycobacterium avium complex in human macrophages. Antimicrob. Agents Chemother. 35:1356-1359.
18. Fernandes, P. B., D. J. Hardy, D. McDaniel, C. W. Hanson, and R. N. Swanson. 1989. In vitro and in vivo activities of clarithromycin against Mycobacterium avium. Antimicrob. Agents Chemother. 33:1531-1534.
19. Brogden, R. N., and A. Fitton. 1994. Rifabutin, a review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 47(6):983-1009.